WEISSMANN; Dinah

Patent Applications and Registrations

Patent applications and USPTO patent grants for WEISSMANN; Dinah.The latest application filed is for "editing profiling of pde8a pre -mrna: use as specific biomarker of adars activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects".

Company Profile

5.5.16

WEISSMANN; Dinah - Paris FR
WEISSMANN; Dinah - St. Mathieu de Treviers FR
WEISSMANN; Dinah - Saint Mathieu de Treviers US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Editing Profiling Of Pde8a Pre -mrna: Use As Specific Biomarker Of Adars Activities In Human Tissues To Diagnose And To Predict And Assess Therapeutic Efficacy And/or Efficiency Or Potential Drug Side Effects App 20220073984 - WEISSMANN; Dinah ; et al.	2022-03-10
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects Grant 10,851,420 - Weissmann , et al. December 1, 2	2020-12-01
Editing Profiling Of Pde8a Pre -mrna: Use As Specific Biomarker Of Adars Activities In Human Tissues To Diagnose And To Predict App 20200032338 - WEISSMANN; Dinah ; et al.	2020-01-30
Algorithm And An In Vitro Method Based On Rna Editing To Select Particular Effect Induced By Active Compounds App 20190249251 - WEISSMANN; Dinah ; et al.	2019-08-15
Rna Editing As Biomarkers For Mood Disorders Test App 20190185937 - SALVETAT; Nicolas ; et al.	2019-06-20
Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects Grant 10,323,283 - Weissmann , et al.	2019-06-18
Editing Profiling Of Pde8a Pre -mrna: Use As Specific Biomarker Of Adars Activities In Human Tissues To Diagnose And To Predict And Assess Therapeutic Efficacy And/or Efficiency Or Potential Drug Side Effects App 20180010184 - WEISSMANN; Dinah ; et al.	2018-01-11
Evaluation Of The Potential Risk Of Drug Induced Mood Disturbance And Suicide: Use Of A Dedicated Platform App 20170253926 - Weissmann; Dinah ; et al.	2017-09-07
Editing Profiling Of Pde8a Pre -mrna: Use As Specific Biomarker Of Adars Activities In Human Tissues To Diagnose And To Predict And Assess Therapeutic Efficacy And/or Efficiency Or Potential Drug Side Effects App 20150056622 - Weissmann; Dinah ; et al.	2015-02-26
Evaluation Of The Potential Risk Of Drug Induced Mood Disturbance And Suicide: Use Of A Dedicated Platform App 20140356875 - Weissmann; Dinah ; et al.	2014-12-04
Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform Grant 8,771,953 - Weissmann , et al. July 8, 2	2014-07-08
Use Of 14,15-dihydro-20,21-dinoreburnamenin-14-ol For The Treatment And/or Prevention Of Serious Depression And Sleep/waking Cycle Disorders App 20130178493 - Pujol; Jean-Francois ; et al.	2013-07-11
Evaluation Of The Potential Risk Of Drug Induced Mood Disturbance And Suicide: Use Of A Dedicated Platform App 20120129177 - Weissmann; Dinah ; et al.	2012-05-24
Use Of 14,15-dihydro-20,21-dinoreburnamenin-14-ol For The Treatment And/or Prevention Of Serious Depression And Sleep/waking Cycle Disorders App 20110201636 - Pujol; Jean-Francois ; et al.	2011-08-18
Peripherical Tissue Sample Containing Cells Expressing The 5htr2c And/or Adars As Markers Of The Alteration Of The Mechanism Of The 5htr2c Mrna Editing And Its Applications App 20100184058 - WEISSMANN; Dinah	2010-07-22
1H-Indole-Pyridinecarboxamide and 1H-Indole-Piperidinecarboxamide Compounds App 20090258883 - Brion; Jean-Daniel ; et al.	2009-10-15
Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof Grant 7,354,918 - Ciapetti , et al. April 8, 2	2008-04-08
Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression and sleep/waking cycle disorders App 20070155769 - Pujol; Jean-Francois ; et al.	2007-07-05
Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof App 20070088046 - Ciapetti; Paola ; et al.	2007-04-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.